The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units

Biochemistry

Volumn 46, Issue 23, 2007, Pages 6957-6970

  Dattilo, Brian M ^a   Fritz, Günter ^b   Leclerc, Estelle ^c   Vander Kooi, Craig W ^a,f   Heizmann, Claus W ^d   Chazin, Walter J ^a,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d Children's Hospital Zurich   (Switzerland)

^e VANDERBILT UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; DYNAMIC LIGHT SCATTERING; MEDICAL PROBLEMS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEINS; SURFACE REACTIONS;

BACTERIAL EXPRESSION SYSTEMS; GLYCATION; INDEPENDENT STRUCTURAL UNITS;

CELL CULTURE;

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM ION; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN; LIGAND; PROTEIN S100B;

ARTICLE; CHRONIC INFLAMMATION; CIRCULAR DICHROISM; DIABETES MELLITUS; DRUG TARGETING; LIGHT SCATTERING; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA; ESCHERICHIA COLI; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS);

EID: 34250171731     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7003735     Document Type: Article

References (66)

1. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J. Biol. Chem. 267, 14998-15004.
2. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., and Clauss, M. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface, J. Biol. Chem. 267, 14987-14997.
3. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., and Stem, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897.
4. Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., and Stem, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions, Arterioscler. Thromb. 14, 1521-1528.
5. Hori, O., Yan, S. D., Ogawa, S., Kuwabara, K., Matsumoto, M., Stern, D., and Schmidt, A. M. (1996) The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus, Nephrol., Dial., Transplant. 11 (Suppl. 5), 13-16.
6. Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., and Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes, J. Clin. Invest. 96, 1395-1403.
7. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., and Horiuchi, S. (1996) N (epsilon)-(carboxymethyl)-lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, Biochemistry 35, 8075-8083.
8. Schmidt, A. M., Yan, S. D., Yan, S. F., and Stern, D. M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498, 99-111.
9. Du Yan, S., Zhu, H., Fu, J., Yan, S. F., Roher, A., Tourtellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D., and Schmidt, A. M. (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 94, 5296-5301.
10. Miyata, T., Hori, O., Zhang, J., Yan, S. D., Ferran, L., Iida, Y., and Schmidt, A. M. (1996) The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis, J. Clin. Invest. 98, 1088-1094.
11. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., and Nitecki, D. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system, J. Biol. Chem. 270, 25752-25761.
12. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., and Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides, Cell 97, 889-901.
13. Arumugam, T., Simeone, D. M., Schmidt, A. M., and Logsdon, C. D. (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE), J. Biol. Chem. 279, 5059-5065.
14. Sorci, G., Riuzzi, F., Agneletti, A. L., Marchetti, C., and Donato, R. (2003) S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner, Mol. Cell. Biol. 23, 4870-4881.
15. Yamagishi, S., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., Shigeto, Y., and Imaizumi, T. (2006) Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects, Metabolism 55, 1227-1231.
16. Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Tamei, H., Matsuki, H., Sakurai, S., Yamamoto, Y., Yonekura, H., Watanabe, T., Yamamoto, H., and Nishizawa, Y. (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis, Arterioscler., Thromb., Vasc. Biol. 25, 2587-2593.
17. Stern, D. M., Yan, S. D., Yan, S. F., and Schmidt, A. M. (2002) Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes, Ageing Res. Rev. 1, 1-15.
18. Stern, D., Yan, S. D., Yan, S. F., and Schmidt, A. M. (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings, Adv. Drug Delives Rev. 54, 1615-1625.
19. Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., and Imaizumi, T. (2003) Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy, Int. J. Clin. Pharmacol. Res. 23, 129-134.
20. Rauvala, H., Merenmies, J., Pihlaskari, R., Korkolainen, M., Huhtala, M. L., and Panula, P. (1988) The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons, J. Cell Biol. 107, 2293-2305.
21. Heizmann, C. W., Fritz, G., and Schafer, B. W. (2002) S100 proteins: structure, functions and pathology, Front. Biosci. 7, d1356-1368.
22. Fages, C., Nolo, R., Huttunen, H. J., Eskelinen, E., and Rauvala, H. (2000) Regulation of cell migration by amphoterin, J. Cell Sci. 113, 611-620.
23. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., and Rauvala, H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation, J. Biol. Chem. 275, 40096-40105.
24. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. M., and Schmidt, A. M. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.-[see comment], Nature 405, 354-360.
25. Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Jr., Chow, W. S., Stern, D., and Schmidt, A. M. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts, Nat. Med. 4, 1025-1031.
26. Hudson, B. I., and Schmidt, A. M. (2004) RAGE: a novel target for drug intervention in diabetic vascular disease, Pharm. Res. 21, 1079-1086.
27. Schmidt, A. M., and Stern, D. M. (2000) RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes, Trends Endocrinol. Metab. 11, 368-375.
28. Hudson, B. I., Bucciarelli, L. G., Wendt, T., Sakaguchi, T., Lalla, E., Qu, W., Lu, Y., Lee, L., Stern, D. M., Naka, Y., Ramasamy, R., Yan, S. D., Yan, S. F., D'Agati, V., and Schmidt, A. M. (2003) Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders, Arch. Biochem. Biophys. 419, 80-88.
29. Davey, G. E., Murmann, P., and Heizmann, C. W. (2001) Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells, J. Biol. Chem. 276, 30819-30826.
30. Rintala-Dempsey, A. C., Santamaria-Kisiel, L., Liao, Y., Lajoie, G., and Shaw, G. S. (2006) Insights into S100 target specificity examined by a new interaction between S100A11 and annexin A2, Biochemistry 45, 14695-14705.
31. Sastry, M., Ketchem, R. R., Crescenzi, O., Weber, C., Lubienski, M. J., Hidaka, H., and Chazin, W. J. (1998) The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins, Structure 6, 223-231.
32. Maler, L., Sastry, M., and Chazin, W. J. (2002) A structural basis for S100 protein specificity derived from comparative analysis of apo and Ca(2+)-calcyclin, J. Mol. Biol. 317, 279-290.
33. Deloulme, J. C., Gentil, B. J., and Baudier, J. (2003) Monitoring of S100 homodimerization and heterodimeric interactions by the yeast two-hybrid system, Microsc. Res. Tech. 60, 560-568.
34. Itou, H., Yao, M., Fujita, I., Watanabe, N., Suzuki, M., Nishihira, J., and Tanaka, I. (2002) The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process. J. Mol. Biol. 316, 265-276.
35. Moroz, O. V., Antson, A. A., Dodson, E. J., Burrell, H. J., Grist, S. J., Lloyd, R. M., Maitland, N. J., Dodson, G. G., Wilson, K. S., Lukanidin, E., and Bronstein, I. B. (2002) The structure of S100A12 in a hexameric form and its proposed role in receptor signalling, Acta Csstallogr., Sect. D: Biol. Crystallogr. 58, 407-413.
36. Machius, M., Cianga, P., Deisenhofer, J., and Ward, E. S. (2001) Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions, J. Mol. Biol. 310, 689-698.
37. Wilton, R., Yousef, M. A., Saxena, P., Szpunar, M., and Stevens, F. J. (2006) Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli, Protein Expression Purif. 47, 25-35.
38. Hanford, L. E., Enghild, J. J., Valnickova, Z., Petersen, S. V., Schaefer, L. M., Schaefer, T. M., Reinhart, T. A., and Oury, T. D. (2004) Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 279, 50019-50024.
39. Ostendorp, T., Weibel, M., Leclerc, E., Kleinert, P., Kroneck, P. M., Heizmann, C. W., and Fritz, G. (2006) Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris, Biochem. Biophys. Res. Commun. 347, 4-11.
40. Huttunen, H. J., Fages, C., and Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways, J. Biol. Chem. 274, 19919-19924.
41. Bork, P., Holm, L., and Sander, C. (1994) The immunoglobulin fold. Structural classification, sequence patterns and common core, J. Mol. Biol. 242, 309-320.
42. Ostendorp, T., Heizmann, C. W., Kroneck, P. M., and Fritz, G. (2005) Purification, crystallization and preliminary X-ray diffraction studies on human Ca2+-binding protein S100B. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 61, 673-675.
43. Andrade, M. A., Chacon, P., Merelo, J. J., and Moran, F. (1993) Evaluation of secondary structure of proteins from UV circular diehroism spectra using an unsupervised learning neural network. Protein Eng. 6, 383-390.
44. Johnsson, B., Lofas, S., and Lindquist, G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268-277.
45. Myszka, D. G. (1999) Improving biosensor analysis. J. Mol. Recognit. 12, 279-284.
46. Roden, L. D., and Myszka, D. G. (1996) Global analysis of a macromolecular interaction measured on BIAcore. Biochem. Biophxs. Res. Commun. 225, 1073-1077.
47. Pervushin, K., Riek, R., Wider, G., and Wuthrich, K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromoleeules in solution, Proc. Natl. Acad. Sci. U.S.A. 94, 12366-12371.
48. Bartels, C. Xia, T., Billeter, M., Guntert, P., and Wuthrich, K. (1995) The program XEASY for computer-supported NMR spectral analysis of biological macromoleeules, J. Biomol. NMR 6, 1-10.
49. Lambert, C., Leonard. N., De Bolle, X., and Depiereux, E. (2002) ESyPred3D: Prediction of proteins 3D structures, Bioinformatics 18, 1250-1256.
50. Canutescu, A. A., Shelenkov, A. A., and Dunbrack, R. L., Jr. (2003) A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 12, 2001-2014.
51. Morris, A. L., MacArthur, M. W., Hutchinson, E. G., and Thornton, J. M. (1992) Stereochemical quality of protein structure coordinates. Proteins 12, 345-364.
52. Renard, C., Chappey, O., Wautier, M. P., Nagashima, M., Lundh, E., Morser, J., Zhao, L., Schmidt, A. M., Scherrmann, J. M., and Wautier, J. L. (1997) Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats, Mol. Pharmacol. 52, 54-62.
53. Chung, C. M., Chiu, J. D., Connors, L. H., Gursky, O., Lim, A., Dykstra, A. B., Liepnieks, J., Benson, M. D., Costello, C. E., Skinner, M., and Walsh, M. T. (2005) Thermodynamic stability of a kappal immunoglobulin light chain: relevance to multiple myeloma. Biophys. J. 88, 4232-4242.
54. Eletsky, A., Kienhofer, A., and Pervushin, K. (2001) TROSY NMR with partially deuterated proteins, J. Biomol. NMR 20, 177-180.
55. Koppal, T., Lam, A. G., Guo, L., and Van Eldik, L. J. (2001) S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia, Neurochem. Int. 39, 401-407.
56. Haspel, J., and Grumet, M. (2003) The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front. Biosci. 8, s1210-1225.
57. Xie, J., Burz, D. S., He, W., Bronstein, I. B., Lednev, I. K., and Shekhtman, A. (2006) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches, J. Biol. Chem. 282, 4218-4231.
58. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.[see comment]. Nature 382, 685-691.
59. Wilder, P. T., Lin, J., Bair, C. L., Charpentier, T. H., Yang, D., Liriano, M., Varney, K. M., Lee, A., Oppenheim, A. B., Adhya, S., Carrier, F., and Weber, D. J. (2006) Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B, Biochim. Biophys. Acta 1763, 1284-1297.
60. Srikrishna, G., Huttunen, H. J., Johansson, L., Weigle, B., Yamaguchi, Y., Rauvala, H., and Freeze, H. H. (2002) N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 80, 998-1008.
61. Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990.
62. Syed, R. S., Rcid, S. W., Li, C. Cheetham, J. C. Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J., Finer-Moore, J., Elliott, S., Sitney, K., Katz, B. A., Matthews, D. J., Wendoloski, J. J., Egrie, J., and Stroud, R. M. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516.
63. Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan. Y., McKinstry, W. J., Palethorpe. K., Seeber, R. M., Monks, T. A., Eidne. K. A., Parker, M. W., and Waters, M. J. (2005) Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 12, 814-821.
64. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., and Kasaoka, T. (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site, FEBS Lett. 550, 107-113.
65. Yonekura, H., Yamamoto, Y., Sakurai, S., Petrova, R. G., Abedin, M. J., Li, H., Yasui, K., Takeuchi, M., Makita, Z., Takasawa, S., Okamoto, H., Watanabe, T., and Yamamoto, H. (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury, Biochem. J. 370, 1097-1109.
66. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. and Ferrin, T. E. (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.